Evidence map›Paper›PMID 30063650›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2018

Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men Who Have Sex With Men.

Lisa A Eaton, Derrick D Matthews, Leigh A Bukowski, M Ruvel Friedman, Cristian J Chandler, Darren L Whitfield, Jordan M Sang, Ron D Stall, POWER Study Team

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Missed Opportunity or Cause for Concern? Methamphetamine Use Is Associated With Greater Interest in Event-Driven PrEP Among Sexual Minority Men.AIDS education and prevention : official publication of the International Society for AIDS Education · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lisa A EatonInstitute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT.
Derrick D Matthews
Leigh A BukowskiBehavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.
M Ruvel Friedman
Cristian J ChandlerBehavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.
Darren L WhitfieldSchool of Social Work, University of Pittsburgh, Pittsburgh, PA.
Jordan M SangBehavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.
Ron D StallBehavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.
POWER Study Team

Funding

Novel Stigma/Structural Interventions for Increasing HIV/STI Testing Among BMSMR01MH109409 · NIMH · UNIVERSITY OF CONNECTICUT STORRS · PI EATON, LISA A · 2016 to 2020
$3.7M
Understanding Delayed Access to HIV Prevention Services among Black MSMR01NR013865 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALBERT, STEVEN M · 2013 to 2017
$3.0M
NIMH NIH HHS R01 MH109409NINR NIH HHS R01 NR013865
6 · The paper itself

Abstract

backgroundThe HIV epidemic among black men who have sex with men (BMSM) demands urgent public health attention. Pre-exposure prophylaxis (PrEP) is a highly efficacious option for preventing HIV, but characteristics of PrEP use among community samples of BMSM are not well-understood.

methodsA serial cross-sectional survey assessment (N = 4184 BMSM reporting HIV-negative/unsure status) and HIV testing were conducted at Black Gay Pride events in 6 US cities in 2014, 2015, 2016, and 2017.

resultsHIV prevalence was higher among BMSM self-reporting current PrEP use (1 of 3 participants) than BMSM not self-reporting current PrEP use (1 of 5 participants) [32.3%, N = 103/319 vs. 20.0%, N = 639/3,193, adjusted odds ratio (aOR) = 1.68, 95% confidence interval (CI): 1.31 to 2.15]. BMSM reporting current PrEP use (N = 380) were more likely to report having a greater number of male sex partners (aOR = 1.02, 95% CI: 1.01 to 1.03), a sexually transmitted infection diagnosis (aOR = 2.44, 95% CI: 1.88 to 3.16), and stimulant drug use (aOR = 2.05, 95% CI, 1.21 to 3.47) when compared with BMSM not reporting current PrEP use (N = 3804). PrEP use increased from 4.7% (2014) to 15.5% (2017) (aOR = 1.19, 95% CI: 1.13 to 1.25). Among PrEP users, inability to afford health care coverage was associated with testing HIV-positive (aOR = 2.10, 95% CI: 1.24 to 3.56).

conclusionsThe high prevalence of HIV infection among BMSM reporting PrEP use is concerning. It does not, however, challenge the efficacy of PrEP itself but rather the uptake of the surrounding preventative package including behavioral risk reduction support, sexually transmitted infection treatment, and medication adherence counseling. Further research to understand barriers to fully effective PrEP is needed to guide operational and behavioral interventions that close the gap on incident infection.

Indexed as

Black PeopleHomosexuality, MaleAdolescentAdultBlack or African AmericanChemopreventionCitiesCross-Sectional StudiesDrug UtilizationFemaleHIV InfectionsHumansMalePre-Exposure ProphylaxisPrevalenceUnited States

Identifiers

PMID30063650
PMCPMC6510021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.